Experimental and Molecular Medicine Korea
Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.
Categories: Biology, Biotech/Biomedical, Business, Cancer, Chemistry, Education, Health & Fitness, Science
Bionic ID: 476870
Advertising Options
Below are Experimental and Molecular Medicine Korea advertising placement options to consider in your media planning and media buying.
-
Billboard Advertising
- 970x250 - Billboard - 970x250
-
Magazine Advertising
- 1/2 Page - 1/2 Page
- 1/3 page - 1/3 page
- 1/4 page - 1/4 page
- 1/6 page - 1/6 page
- Full Page - Full Page
- Half page - Half page
-
Online Display Advertising
- 160x600 - Wide Skyscraper - 160x600
- 300x250 - Medium Rectangle - 300x250
- 300x600 - Half Page - 300x600
- 728x90 - Leaderboard - 728x90
Learn More
To learn more about the Experimental and Molecular Medicine Korea program, submit a request for information. Your request will be sent immediately to the Springer Nature ad sales team.
Place an Order
To place an order, contact Experimental and Molecular Medicine Korea or order electronically through Bionic Media Buying Software using ID 476870.